Article
Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols.
British journal of cancer - 1 May 1995
Borg A, Lennerstrand J, Stenmark-Askmalm M, Fernö M, Brisfors A, Ohrvik A, Stål O, Killander D, Lane D, Brundell J
Abstract excerpt
A novel quantitative luminometric immunoassay (LIA) has been developed for the measurement of wild-type and mutant p53 protein in extracts from breast tumour tissue. The LIA was found to yield reliable estimates of p53 expression in cytosol samples routinely prepared for steroid receptor analysis as compared with results obtained with immunohistochemical analysis. The LIA was evaluated on 205 primary breast...
Topics
- Breast Neoplasms
- Cytosol
- Evaluation Studies as Topic
- Female
- Gene Expression
- Genes, p53
- Humans
- Immunohistochemistry
- Luminescent Measurements
- Mutation
- Phenotype
